BI 765423 clinical trials

A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

This study looks at a new medicine, BI 765423, for Idiopathic Pulmonary Fibrosis (IPF). It aims to see if this medicine can improve lung function in adults with IPF, comparing it to a dummy treatment over three months.